# Privia Health Group, Inc. (PRVA) · Edgar & Edgarette company card

> Privia Health Group (PRVA) grew revenue 22.3% in FY2025 to $2.1 billion, operating margin 1.6% against a -3.3% median for health services, equity 53.8% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1759655 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/PRVA) · [JSON](https://www.pops4.com/boards/company/PRVA.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $2.1B |
| Revenue growth, 1 year | 22.3% |
| Revenue growth per year | 21.7% |
| Operating margin | 1.6% (prior year 1.0%) |
| Net margin | 1.4% |
| Operating cash flow | $163M |
| Capital spending | — |
| Free cash flow | — |
| Cash | $480M |
| Long-term debt | — |
| Total assets | $1.4B |
| Total equity | $737M |
| Equity ÷ assets | 53.8% |
| Return on equity | 4.0% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: 2.77 (safe zone)
- Piotroski F: 6 of 9 (solid)
- Health Harbor boat: New ship · no warning signs
- Cash Compass: Fast, cash not yet · growing fast, but little cash arriving so far

## Edgarette's reading

Exposure: revenue $2.1B (FY2025). Experience: revenue up 22.3% on the year, up 21.7% a year over 4 years; operating margin 1.6%, up from 1.0%. Soundness: equity 53.8% of assets, return on equity 4.0%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $2.1B and $2.9B next year (method v4.1: its own 4-year record of growth weighed at 50% against $1B–10B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $1.9B to $3.2B. A statistical range, not company guidance. Against peers (10 filers, $50M+ revenue, services-health services): operating margin 1.6% against a -3.3% median; growth 22.3% against 19.2%.

Range logged 2026-09-27, receipt bfeec697833bd1b2, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 2, latest 2026-08-18 ([filing](https://www.sec.gov/Archives/edgar/data/1759655/000175965526000068/0001759655-26-000068-index.htm))

## Recent filings

- 8-K · filed 2026-11-18 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1759655/000175965526000087/0001759655-26-000087-index.htm)
- 10-Q · filed 2026-11-05 · [filing](https://www.sec.gov/Archives/edgar/data/1759655/000175965526000085/0001759655-26-000085-index.htm)
- 8-K · filed 2026-11-05 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1759655/000175965526000083/0001759655-26-000083-index.htm)
- 8-K · filed 2026-08-18 · 5.02 Departure or Election of Directors; Appointment of Officers; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1759655/000175965526000068/0001759655-26-000068-index.htm)
- 10-Q · filed 2026-08-06 · [filing](https://www.sec.gov/Archives/edgar/data/1759655/000175965526000064/0001759655-26-000064-index.htm)
- 8-K · filed 2026-08-06 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1759655/000175965526000061/0001759655-26-000061-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001759655.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1759655

## Cite

POPS4, Edgar & Edgarette: Privia Health Group, Inc. (PRVA) company card, from the company's own SEC filings, accessed 2026-11-19, https://www.pops4.com/boards/company/PRVA. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.

